Innovative Pharmaceutical Biotech - 股票

Innovative Pharmaceutical Biotech 权益回报率 2024

Innovative Pharmaceutical Biotech 权益回报率

0.31

股票代码

399.HK

ISIN

BMG4783W1073

WKN

A1416X

在2024年,Innovative Pharmaceutical Biotech的股本回报率(ROE)为0.31,较上一年的-0.08 ROE增长了-470.65%

Innovative Pharmaceutical Biotech Aktienanalyse

Innovative Pharmaceutical Biotech在做什么?

The company Innovative Pharmaceutical Biotech Ltd is a company that is active in the field of biotechnological and pharmaceutical research and development. The company has its roots in the research and development of innovative active substances and drugs. The company's history began in the 1990s, when a group of scientists came together to bundle their expertise and visions and develop innovative solutions in the field of active substance research. They founded Innovative Pharmaceutical Biotech Ltd as an independent company in 2000. The company's business model is based on the research and development of new active substances and drugs in the field of oncology, neurology, and immunology. The company follows an insistence-driven approach, aiming to develop active substances with innovative mechanisms of action that are superior to proven therapeutic approaches. Innovative Pharmaceutical Biotech Ltd collaborates with a broad network of partners and cooperation partners, including academic research institutions, clinical centers, biotech companies, and pharmaceutical companies. The company cooperates with companies from all over the world and operates worldwide. The company has various divisions, each focusing on the development of active substances and drugs in specific medical fields. In the oncology division, the company develops active substances and drugs for the treatment of cancer. In the neurology division, active substances and drugs for the treatment of neurological diseases such as Alzheimer's and Parkinson's are researched and developed. The immunology division of the company is dedicated to the development of active substances and drugs for the treatment of immune system diseases such as autoimmune diseases and inflammations. Over the years, the company has developed and launched a number of products. One of its most important products is an active substance for the treatment of breast cancer, which has shown promising results in clinical studies. The company has also developed a treatment for the relief of pain in cancer and other patients based on chemotherapy symptoms. In addition to its research and development efforts, Innovative Pharmaceutical Biotech Ltd attaches great importance to compliance with standards and regulations in the pharmaceutical and biotechnological industry. The company maintains strict quality control procedures and strives to adhere to the highest standards in drug manufacturing. Innovative Pharmaceutical Biotech Ltd sees itself as a pioneer in the pharmaceutical and biotechnological industry and takes pride in developing innovative solutions that have the potential to improve the lives of people around the world. The company has a variety of partners and cooperation partners worldwide and is proud to have a global presence in the field of biotechnological and pharmaceutical research and development. In summary, Innovative Pharmaceutical Biotech Ltd is a company that focuses on the research and development of innovative active substances and drugs that have the potential to improve the lives of people worldwide. The company collaborates with a broad network of partners and cooperation partners and maintains strict quality control procedures to adhere to the highest standards in drug manufacturing. The translation is as accurate as possible. Innovative Pharmaceutical Biotech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

权益回报率的详细信息

Innovative Pharmaceutical Biotech的股本回报率(ROE)解密

Innovative Pharmaceutical Biotech的股本回报率(ROE)是一项基本的指标,用于评估公司相对于自有资本的盈利能力。ROE通过将净利润除以股东的股权来计算,展示了公司从股东投资中获取收益的效率。较高的ROE代表着增加的效率和盈利能力。

年度比较

对Innovative Pharmaceutical Biotech的ROE进行年度比较分析有助于追踪盈利趋势和财务表现。ROE的上升表明了盈利能力和为股东创造价值的增加,而ROE的下降则可能表明了盈利或者资本管理方面的问题。

对投资的影响

Innovative Pharmaceutical Biotech的ROE对评估公司的盈利能力、效率和投资吸引力的投资者来说是至关重要的。强大的ROE显示出公司将股权投资转化为盈利的能力,从而增加了其对潜在和现有投资者的吸引力。

对ROE波动的解读

Innovative Pharmaceutical Biotech的ROE的变化可能源于净利润、股权或两者的波动。这些波动被用来评估管理效率、财务策略及其相关的风险和机会,并帮助投资者做出明智的决策。

关于Innovative Pharmaceutical Biotech股票的常见问题

Innovative Pharmaceutical Biotech今年的股本回报率(ROE)有多高?

Innovative Pharmaceutical Biotech今年的ROE为0.31 undefined。

Innovative Pharmaceutical Biotech的股权回报率(ROE)与去年相比有何变化?

与去年相比,Innovative Pharmaceutical Biotech的ROE已经下降了-470.65%。

Innovative Pharmaceutical Biotech的高ROE(股本回报率)对投资者有什么影响?

一个高ROE表明Innovative Pharmaceutical Biotech获得了良好的资本回报,并成功地将其投资变现。对投资者来说,这是一个积极的指标。

Innovative Pharmaceutical Biotech的投资者,低ROE(股权回报率)会有什么影响?

一个较低的ROE可能表明Innovative Pharmaceutical Biotech在成功地将其投资变现方面面临困难,这可能对投资者来说是一个负面的信号。

Innovative Pharmaceutical Biotech的权益回报率(ROE)变化会对公司产生什么影响?

ROE(股东权益回报率)的变动Innovative Pharmaceutical Biotech可能是衡量公司财务表现的指标,并显示该公司与同行业其他公司相比有多成功。

如何计算Innovative Pharmaceutical Biotech的ROE(股本回报率)?

ROE(股本回报率)的计算方法是将公司的利润除以总股本。公式为:ROE = 利润 / 总股本。

Innovative Pharmaceutical Biotech的股本回报率(ROE)受哪些因素影响?

影响Innovative Pharmaceutical Biotech的股权回报率(ROE)的一些因素包括资本利用效率,公司的盈利能力和融资结构等。

可以采取哪些战略措施来提高ROE(股本回报率)?

为了提高的股本回报率(ROE),可以采取诸如削减成本、提高销售额、提高使用股本的效率以及在融资结构中进行更改等措施。重要的是,公司需要对其财务状况进行深入审查,以确定最佳的战略措施以提高股本回报率(ROE)。

Innovative Pharmaceutical Biotech支付多少股息?

在过去的12个月中,Innovative Pharmaceutical Biotech支付了 的股息。这相当于大约的股息收益率。在未来的12个月内,Innovative Pharmaceutical Biotech预计将支付0 HKD的股息。

Innovative Pharmaceutical Biotech的股息收益率有多高?

Innovative Pharmaceutical Biotech当前的股息收益率为。

Innovative Pharmaceutical Biotech什么时候支付股息?

Innovative Pharmaceutical Biotech按季度支付股息。这些股息将在月份分发。

Innovative Pharmaceutical Biotech的股息有多安全?

Innovative Pharmaceutical Biotech 在过去0年里每年都支付了股息。

Innovative Pharmaceutical Biotech的股息有多高?

预计未来12个月的股息将达到0 HKD。这相当于0 %的股息收益率。

Innovative Pharmaceutical Biotech位于哪个行业?

Innovative Pharmaceutical Biotech 被分配到“工业”板块。

Wann musste ich die Aktien von Innovative Pharmaceutical Biotech kaufen, um die vorherige Dividende zu erhalten?

要获得Innovative Pharmaceutical Biotech在支付的0.02 HKD的最后一笔股息,你必须在的除息日之前持有该股票于你的账户中。

Innovative Pharmaceutical Biotech最后一次支付股息是什么时候?

上一次股息发放日期为。

Innovative Pharmaceutical Biotech在2023年的股息是多少?

在2023年,Innovative Pharmaceutical Biotech 分配了0 HKD作为股息。

Innovative Pharmaceutical Biotech 的股息是以哪种货币支付的?

Innovative Pharmaceutical Biotech的股息将以HKD的形式分配。

股票储蓄计划为投资者提供了一种吸引人的方法,可以长期累积财富。主要优势之一是所谓的成本平均效应:通过定期投入固定金额于股票或股票基金,当价格低时自动买入更多份额,价格高时买入较少,这可能随着时间带来更优惠的平均每份成本。此外,股票储蓄计划还允许小额投资者接触到高价股票,因为他们可以用很小的金额参与其中。定期投资也促进了一种纪律投资策略,并有助于避免情绪化的决策,如冲动买卖。除此之外,投资者还能从股票的潜在增值以及可以再投资的股息分红中获益,这增强了复利效应,从而增加了投资资本的增长。

Andere Kennzahlen von Innovative Pharmaceutical Biotech

我们对Innovative Pharmaceutical Biotech 营业额股票的股票分析包括重要的财务指标,如收入、利润、市盈率、市销率、息税折旧摊销前利润,以及有关股息的信息。此外,我们还研究了诸如股票、市值、债务、股东权益和Innovative Pharmaceutical Biotech 营业额的负债等方面。如果您在寻找关于这些主题的更详细信息,我们在子页面上提供了详细的分析: